ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma
August 03, 2020The approval is based on results from the Phase III IMspire150 study, in which the addition of Tecentriq to Cotellic and Zelboraf helped people live longer without disease worsening or death. -
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer
November 08, 2017The U.S. Food and Drug Administration has expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood -
FDA approves Zelboraf for certain patients with Erdheim-Chester disease
November 08, 2017The FDA has expanded the approval of Zelboraf to include the treatment of certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood…
Pharma Sources Insight January 2025
